SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-007454
Filing Date
2023-03-13
Accepted
2023-03-13 08:30:58
Documents
12
Period of Report
2023-03-13
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K crnx-20230313.htm   iXBRL 8-K 47913
  Complete submission text file 0000950170-23-007454.txt   160180

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crnx-20230313_lab.xml EX-101.LAB 12806
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crnx-20230313_pre.xml EX-101.PRE 9455
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crnx-20230313.xsd EX-101.SCH 2472
6 EXTRACTED XBRL INSTANCE DOCUMENT crnx-20230313_htm.xml XML 4549
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 23725830
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences